306.23
price down icon2.46%   -7.8932
 
loading
HCA Healthcare Inc stock is currently priced at $306.23, with a 24-hour trading volume of 1.74M. It has seen a -2.46% decreased in the last 24 hours and a -6.50% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $316.2 pivot point. If it approaches the $306.0 support level, significant changes may occur.
Previous Close:
$314.12
Open:
$297.38
24h Volume:
1.74M
Market Cap:
$79.05B
Revenue:
$64.97B
Net Income/Loss:
$5.24B
P/E Ratio:
15.06
EPS:
20.33
Net Cash Flow:
$4.69B
1W Performance:
+0.42%
1M Performance:
-6.50%
6M Performance:
+38.14%
1Y Performance:
+10.19%
1D Range:
Value
$295.79
$306.97
52W Range:
Value
$215.96
$335.83

HCA Healthcare Inc Stock (HCA) Company Profile

Name
Name
HCA Healthcare Inc
Name
Phone
615-344-9551
Name
Address
One Park Plaza, Nashville, TN
Name
Employee
190,000
Name
Twitter
@hcahealthcare
Name
Next Earnings Date
2024-05-14
Name
Latest SEC Filings
Name
HCA's Discussions on Twitter

HCA Healthcare Inc Stock (HCA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-04-24 Downgrade Bernstein Outperform → Mkt Perform
Dec-11-23 Downgrade Goldman Buy → Neutral
Apr-21-23 Initiated Cantor Fitzgerald Overweight
Apr-19-23 Resumed JP Morgan Neutral
Jul-06-22 Downgrade BMO Capital Markets Market Perform → Underperform
Jun-17-22 Initiated Loop Capital Buy
May-27-22 Upgrade Bernstein Mkt Perform → Outperform
Mar-29-22 Initiated Wells Fargo Equal Weight
Jan-10-22 Resumed Citigroup Buy
Dec-21-21 Downgrade JP Morgan Overweight → Neutral
Sep-27-21 Initiated SVB Leerink Outperform
Sep-24-21 Initiated UBS Buy
Sep-10-21 Initiated Cowen Outperform
Aug-12-21 Downgrade Barclays Overweight → Equal Weight
Jul-09-21 Initiated Seaport Global Securities Buy
May-13-21 Resumed Citigroup Neutral
Apr-26-21 Downgrade Citigroup Buy → Neutral
Dec-15-20 Initiated Goldman Buy
Dec-14-20 Upgrade JP Morgan Neutral → Overweight
Sep-21-20 Downgrade JP Morgan Overweight → Neutral
Jul-13-20 Downgrade BMO Capital Markets Outperform → Market Perform
Sep-06-19 Upgrade BofA/Merrill Underperform → Neutral
Jul-10-19 Upgrade Goldman Neutral → Buy
Apr-23-19 Upgrade Raymond James Mkt Perform → Outperform
Jan-14-19 Initiated Stephens Overweight
Jan-03-19 Initiated Deutsche Bank Buy
Nov-16-18 Initiated UBS Buy
Mar-23-18 Resumed Mizuho Buy
Jan-03-18 Initiated Goldman Neutral
Jan-03-18 Downgrade Piper Jaffray Overweight → Neutral
Dec-20-17 Downgrade Morgan Stanley Equal-Weight → Underweight
Dec-12-17 Upgrade Citigroup Neutral → Buy
Nov-30-17 Upgrade JP Morgan Neutral → Overweight
Nov-06-17 Reiterated Citigroup Neutral
Nov-01-17 Reiterated Mizuho Buy
Jul-26-17 Downgrade BofA/Merrill Buy → Neutral
Jun-28-17 Initiated Argus Buy
View All

HCA Healthcare Inc Stock (HCA) Financials Data

HCA Healthcare Inc (HCA) Revenue 2024

HCA reported a revenue (TTM) of $64.97 billion for the quarter ending December 31, 2023, a +7.86% rise year-over-year.
loading

HCA Healthcare Inc (HCA) Net Income 2024

HCA net income (TTM) was $5.24 billion for the quarter ending December 31, 2023, a -7.11% decrease year-over-year.
loading

HCA Healthcare Inc (HCA) Cash Flow 2024

HCA recorded a free cash flow (TTM) of $4.69 billion for the quarter ending December 31, 2023, a +13.57% increase year-over-year.
loading

HCA Healthcare Inc (HCA) Earnings per Share 2024

HCA earnings per share (TTM) was $18.98 for the quarter ending December 31, 2023, a -1.30% decline year-over-year.
loading

HCA Healthcare Inc Stock (HCA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Wasserman Chad J
SVP and CIO
Mar 20 '24
Sale
330.25
876
289,299
1,576
Wasserman Chad J
SVP and CIO
Mar 18 '24
Option Exercise
101.16
2,100
212,436
4,020
Wasserman Chad J
SVP and CIO
Mar 18 '24
Sale
321.97
344
110,758
2,452
Whalen Kathleen M
SVP & Chief Ethics Officer
Feb 09 '24
Sale
306.21
4,262
1,305,074
10,250
Torres Kathryn A.
SVP-Payer Contracting & Align.
Feb 06 '24
Option Exercise
173.12
2,092
362,167
21,717
RUTHERFORD BILL B
CFO and EVP
Feb 06 '24
Sale
310.63
6,000
1,863,780
8,448
Whalen Kathleen M
SVP & Chief Ethics Officer
Feb 05 '24
Option Exercise
82.82
8,550
708,084
18,800
Wyatt Christopher F.
SVP & Controller
Feb 05 '24
Sale
312.42
4,000
1,249,680
37,383
Mosier Sammie S
SVP & Chief Nurse Executive
Feb 05 '24
Sale
312.00
1,645
513,240
7,646
Mosier Sammie S
SVP & Chief Nurse Executive
Feb 02 '24
Option Exercise
231.79
6,298
1,459,806
14,315
HCA Healthcare, Inc., through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling. In addition, the company operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. As of February 12, 2018, it owned and operated 179 hospitals and 120 freestanding surgery centers, and various other healthcare facilities in 20 states and the United Kingdom. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
medical_care_facilities FMS
$20.09
price down icon 0.62%
medical_care_facilities DVA
$133.66
price up icon 0.75%
medical_care_facilities UHS
$166.99
price up icon 1.28%
medical_care_facilities THC
$96.80
price down icon 0.66%
medical_care_facilities CHE
$562.98
price down icon 2.06%
Cap:     |  Volume (24h):